Skip to main content

Certain Pesticides Tied to Increased Prostate Cancer Incidence, Mortality

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 4, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Nov. 4, 2024 -- Some pesticides are associated with increased prostate cancer incidence and mortality, according to a study published online Nov. 4 in Cancer.

Simon John Christoph Soerensen, M.D., from the Stanford University School of Medicine in California, and colleagues examined the potential role of agricultural pesticide exposure in prostate cancer incidence and mortality. The annual use of 295 distinct pesticides was measured and the associations with prostate cancer incidence and mortality rates in the contiguous United States were assessed. Data were analyzed for 1997-2001 pesticide use with 2011-2015 outcomes and 2002-2006 pesticide use with 2016-2020 outcomes (discovery and replication cohorts, respectively).

The researchers found that across both cohorts, 22 pesticides showed consistent, direct associations with prostate cancer incidence. Four of these pesticides were also associated with prostate cancer mortality. Each one-standard deviation increase in log-transformed pesticide use corresponded to incidence increases per 100,000 individuals in the replication cohort (6.56, 6.18, 3.20, and 2.82 for trifluralin, cloransulam‐methyl, diflufenzopyr, and thiamethoxam, respectively).

"Public health efforts to reduce the burden of prostate cancer should consider pesticides as environmental exposures that may contribute to the incidence of, and mortality related to, prostate cancer," the authors write

Two authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2024

Read this next

Higher Heathy Eating Index Score Beneficial in Prostate Cancer

THURSDAY, Oct. 24, 2024 -- Higher adherence to American dietary guideline recommendations may be associated with a lower risk for grade reclassification in men diagnosed with...

Stereotactic Body Radiotherapy Viable Alternative for Localized Prostate Cancer

THURSDAY, Oct. 17, 2024 -- Stereotactic body radiotherapy (SBRT) is noninferior to conventional or moderately fractionated radiotherapy for localized prostate cancer (PC)...

Radon Exposure Tied to Higher Risk for Childhood Leukemia

WEDNESDAY, Oct. 16, 2024 -- Exposure to radon levels, even below current recommended levels, heightens the risk for childhood leukemia, according to a study published in the...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.